Novostia Announces New CEO and Secures Additional CHF 5.6 million in Funding
LAUSANNE, Switzerland–(BUSINESS WIRE)– Novostia, a pioneering medical technology company, specializing in the development of a disruptive heart valve prosthesis, at clinical stage, today announces a...